# Heart Failure Mortality Prediction Model Summary

## Executive Summary

This model predicts the risk of death (DEATH_EVENT) in patients with heart failure using clinical and demographic features. It demonstrates good discrimination with an AUC of 0.86 and solid overall accuracy of 82%. The underlying data is generally complete but has moderate concerns due to outliers and about 10% anomalous rows, which may affect model reliability.

## Performance

- **AUC:** 0.859
- **Accuracy:** 0.817
- **F1 score (positive class):** 0.667

The model shows strong ability to distinguish between patients who survive and those who do not, as indicated by the AUC near 0.86. The accuracy of approximately 82% suggests it correctly classifies most cases overall. The F1 score of 0.67 reflects a balanced performance in identifying death events, though there is room for improvement in sensitivity or precision.

## Feature Importance

Feature importance is based on SHAP values, which quantify each feature's contribution to the model's predictions. The top feature, 'time' (duration of follow-up), has the greatest impact on risk prediction. Lower 'ejection_fraction' values increase risk, indicating poorer heart function raises mortality risk. Higher 'serum_creatinine' levels, reflecting kidney function impairment, also increase risk. Older age and presence of diabetes further elevate risk. Other features like 'sex', 'creatinine_phosphokinase', and 'serum_sodium' contribute to risk but to a lesser extent. Overall, these features align with clinical understanding of heart failure prognosis.

## Data Quality Considerations

The data quality status is WARN due to moderate concerns. While there are no missing or duplicate values and data types are appropriate, several numeric features such as 'creatinine_phosphokinase', 'platelets', and 'serum_creatinine' contain notable outliers. Additionally, about 10% of rows were flagged as anomalous by IsolationForest, possibly representing unusual patient profiles or data errors. These issues could bias the model or reduce its stability if not addressed, limiting trust in predictions for certain cases.

## Recommendations

It is recommended to further investigate and manage outliers in key numeric features, potentially by capping or transforming values based on clinical context. Review the anomalous rows to determine if they represent valid extreme cases or errors; consider excluding or modeling them separately. Employing robust scaling or outlier-resistant methods can improve model robustness. Clinicians should be cautious when applying the model to patients with extreme lab values or unusual profiles. Continued monitoring and validation with new data are advised to ensure reliable performance.
